Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats

Brain Research

Volumn 1407, Issue , 2011, Pages 79-89

  Rathbone, Michel P ^a   Saleh, Tarek M ^b   Connell, Barry J ^b   Chang, Ruby ^a,c   Su, Caixin ^a,c   Worley, Brandon ^a   Kim, Minji ^a,c   Jiang, Shucui ^a,c  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Animal behavior; Guanosine; Infarct volume; Neuroprotection; Purine; Stroke

Indexed keywords

CALCIUM; CALPAIN 2; GUANOSINE; HEAT SHOCK PROTEIN 70;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL DEATH; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FOOD INTAKE; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BODY WEIGHT; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GUANOSINE; HEAT-SHOCK PROTEINS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MEMBRANE GLYCOPROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

ANIMALIA; RATTUS;

EID: 79960989069     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.06.027     Document Type: Article

References (50)

1. Adams, R.J., Albers, G., Alberts, M.J., Benavente, O., Furie, K., Goldstein, L.B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S.C., Katzan, I., Kelly-Hayes, M., Kenton, E.J., Marks, M., Sacco, R.L., Schwamm, L., Association, American Heart, Association, American Stroke, 2008. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39, 1647-1652.
2. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L., Teal, P., 2004. Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126, 483S-512S.
3. Alonso de Lecinana, M., Diez-Tejedor, E., Gutierrez, M., Guerrero, S., Carceller, F., Roda, J.M., 2005. New goals in ischemic stroke therapy: the experimental approach - harmonizing science with practice. Cerebrovasc. Dis. 20 (Suppl. 2), 159-168.
4. Chang, R., Algird, A., Bau, C., Rathbone, M.P., Jiang, S., 2008. Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci. Lett. 431, 101-105.
5. Ciccarelli, R., Ballerini, P., Sabatino, G., Rathbone, M.P., D'Onofrio, M., Caciagli, F., Di Iorio, P., 2001. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19, 395-414.
6. Connell, B.J., Saleh, T.M., 2010. A novel rodent model of reperfusion injury following occlusion of the middle cerebral artery. J. Neurosci. Methods 190, 28-33.
7. Connell, B.J., Crosby, K.M., Richard, M.J., Mayne, M.B., Saleh, T.M., 2007. Estrogen-mediated neuroprotection in the cortex may require NMDA receptor activation. Neuroscience 146, 160-169. (Pubitemid 46654612)
8. Crosby, K.M., Connell, B.J., Saleh, T.M., 2007. Estrogen limits ischemic cell death by modulating caspase-12-mediated apoptotic pathways following middle cerebral artery occlusion. Neuroscience 146, 1524-1535. (Pubitemid 46783207)
9. Di Iorio, P., Kleywegt, S., Ciccarelli, R., Traversa, U., Andrew, C.M., Crocker, C.E., Werstiuk, E.S., Rathbone, M.P., 2002. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38, 179-190.
10. DiIorio, P., Ballerini, P., Traversa, U., Nicoletti, F., D'Alimonte, I., Kleywegt, S., Werstiuk, E.S., Rathbone, M.P., Caciagli, F., Ciccarelli, R., 2004. The antiapoptotic effect of guanosine is mediated by the activation of PI 3-Kinase/AKT/PKB pathway in cultured rat astrocytes. Glia 46, 356-368. (Pubitemid 38679194)
11. Durukan, A., Tatlisumak, T., 2007. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav. 87, 179-197.
12. Fisher, M., Brott, T.G., 2003. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke 34, 359-361. (Pubitemid 36206323)
13. Garcia, J.H., Wagner, S., Liu, K.F., Hu, X.J., 1995. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26, 627-635.
14. Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K.R., Medeghri, Z., Machnig, T., Schneider, D., von Kummer, R., Wahlgren, N., Toni, D., 2008. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329.
15. Hazell, A.S., 2007. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 50, 941-953.
16. Hong, S.C., Goto, Y., Lanzino, G., Soleau, S., Kassell, N.F., Lee, K.S., 1994. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25, 663-669. (Pubitemid 24067083)
17. Jiang, S., Khan, M.I., Lu, Y., Wang, J., Buttigieg, J., Werstiuk, E.S., Ciccarelli, R., Caciagli, F., Rathbone, M.P., 2003. Guanosine promotes myelination and functional recovery in chronic spinal injury. Neuroreport 14, 2463-2467.
18. Jiang, S., Bendjelloul, F., Ballerini, P., D'Alimonte, I., Nargi, E., Jiang, C., Huang, X., Rathbone, M.P., 2007. Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic Signal. 3, 411-421.
19. Jiang, S., Ballerini, P., Buccella, S., Giuliani, P., Jiang, C., Huang, X., Rathbone, M.P., 2008a. Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine. Purinergic Signal. 4, 61-71.
20. Jiang, S., Fischione, G., Giuliani, P., Romano, S., Caciagli, F., DiIorio, P., 2008b. Metabolism and distribution of guanosine given intraperitoneally: implications for spinal cord injury. Nucleosides Nucleotides Nucleic Acids 27, 673-680. (Pubitemid 351948543)
21. Lapchak, P.A., Araujo, D.M., 2007. Advances in ischemic stroke treatment: neuroprotective and combination therapies. Expert Opin. Emerg. Drugs 12, 97-112.
22. Moretto, M.B., Arteni, N.S., Lavinsky, D., Netto, C.A., Rocha, J.B., Souza, D.O., Wofchuk, S., 2005. Hypoxic-ischemic insult decreases glutamate uptake by hippocampal slices from neonatal rats: prevention by guanosine. Exp. Neurol. 195, 400-406.
23. Moretto, M.B., Boff, B., Lavinsky, D., Netto, C.A., Rocha, J.B., Souza, D.O., Wofchuk, S.T., 2009. Importance of schedule of administration in the therapeutic efficacy of guanosine: early intervention after injury enhances glutamate uptake in model of hypoxia-ischemia. J. Mol. Neurosci. 38, 216-219.
24. Paxinos, G., Watson, C., 1998. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
25. Peng, L., Huang, R., Yu, A.C., Fung, K.Y., Rathbone, M.P., Hertz, L., 2005. Nucleoside transporter expression and function in cultured mouse astrocytes. Glia 52, 25-35. (Pubitemid 41532134)
26. Pettifer, K.M., Kleywegt, S., Bau, C.J., Ramsbottom, J.D., Vertes, E., Ciccarelli, R., Caciagli, F., Werstiuk, E.S., Rathbone, M.P., 2004. Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport 15, 833-836. (Pubitemid 38453468)
27. Pettifer, K.M., Jiang, S., Bau, C., Ballerini, P., D'Alimonte, I., Werstiuk, E.S., Rathbone, M.P., 2007. MPP+-induced cytotoxicity in neuroblastoma cells: antagonism and reversal by guanosine. Purinergic Signal. 3, 399-409.
28. Rathbone, M., Pilutti, L., Caciagli, F., Jiang, S., 2008. Neurotrophic effects of extracellular guanosine. Nucleosides Nucleotides Nucleic Acids 27, 666-672. (Pubitemid 351948576)
29. Reglodi, D., Tamás, A., Lengvári, I., 2003. Examination of sensorimotor performance following middle cerebral artery occlusion in rats. Brain Res. Bull. 59, 459-466.
30. Saleh, M.C., Connell, B.J., Saleh, T.M., 2009. Estrogen may contribute to ischemic tolerance through modulation of cellular stress-related proteins. Neurosci. Res. 63, 273-279.
31. Saleh, M.C., Connell, B.J., Saleh, T.M., 2010. Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors. Neuroscience 166, 445-454.
32. Sareen, D., Darjatmoko, S.R., Albert, D.M., Polans, A.S., 2007. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol. Pharmacol. 72, 1466-1475.
33. Saute, J.A., da Silveira, L.E., Soares, F.A., Martini, L.H., Souza, D.O., Ganzella, M., 2006. Amnesic effect of GMP depends on its conversion to guanosine. Neurobiol. Learn. Mem. 85, 206-212.
34. Sautin, Y.Y., Johnson, R.J., 2008. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27, 608-619. (Pubitemid 351948591)
35. Savitz, S.I., Fisher, M., 2007a. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann. Neurol. 61, 396-402.
36. Savitz, S.I., Fisher, M., 2007b. Prophylactic neuroprotection. Curr. Drug Targets 8, 846-849. (Pubitemid 47163395)
37. Schmidt, A.P., Tort, A.B., Souza, D.O., Lara, D.R., 2008. Guanosine and its modulatory effects on the glutamatergic system. Eur. Neuropsychopharmacol. 18, 620-622.
38. Shuaib, A., 2006. Neuroprotection - STAIR-way to the future? Cerebrovasc. Dis. 22 (Suppl. 1), 10-17.
39. Su, C., Elfeki, N., Ballerini, P., D'Alimonte, I., Bau, C., Ciccarelli, R., Caciagli, F., Gabriele, J., Jiang, S., 2009. Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J. Neurosci. Res. 87, 617-625.
40. Tamura, A., Graham, D.I., McCulloch, J., Teasdale, G.M., 1981. Focal cerebral ischaemia in the rat: 2. regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1, 61-69.
41. Tavares, R.G., Schmidt, A.P., Tasca, C.I., Souza, D.O., 2008. Quinolinic acid-induced seizures stimulate glutamate uptake into synaptic vesicles from rat brain: effects prevented by guanine-based purines. Neurochem. Res. 33, 97-102.
42. Torres, F.V., da Silva Filho, M., Antunes, C., Kalinine, E., Antoniolli, E., Portela, L.V., Souza, D.O., Tort, A.B., 2010. Electrophysiological effects of guanosine and MK-801 in a quinolinic acid-induced seizure model. Exp. Neurol. 221, 296-306.
43. Traversa, U., Bombi, G., Di Iorio, P., Ciccarelli, R., Werstiuk, E.S., Rathbone, M.P., 2002. Specific [(3)H]-guanosine binding sites in rat brain membranes. Br. J. Pharmacol. 135, 969-976.
44. Traversa, U., Bombi, G., Camaioni, E., Macchiarulo, A., Costantino, G., Palmieri, C., Caciagli, F., Pellicciari, R., 2003. Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg. Med. Chem. 11, 5417-5425.
45. Uemura, Y., Miller, J.M., Matson, W.R., Beal, M.F., 1991. Neurochemical analysis of focal ischemia in rats. Stroke 22, 1548-1553.
46. Vannorsdall, T.D., Jinnah, H.A., Gordon, B., Kraut, M., Schretlen, D.J., 2008. Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke 39, 3418-3420.
47. Vinadé, E.R., Izquierdo, I., Lara, D.R., Schmidt, A.P., Souza, D.O., 2004. Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice. Neurobiol. Learn. Mem. 81, 137-143.
48. Waring, W.S., 2002. Uric acid: an important antioxidant in acute ischaemic stroke. QJM 95, 691-693. (Pubitemid 35203638)
49. Warner, D.S., Sheng, H., Batinic-Haberle, I., 2004. Oxidants, antioxidants and the ischemic brain. J. Exp. Biol. 207, 3221-3231.
50. Zhang, R.L., Chopp, M., Jiang, N., Tang, W.X., Prostak, J., Manning, A.M., Anderson, D.C., 1995. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26, 1438-1442.